Literature DB >> 22271808

Diagnostic management of chronic obstructive pulmonary disease.

B D L Broekhuizen1, A P E Sachs, A W Hoes, T J M Verheij, K G M Moons.   

Abstract

Detection of early chronic obstructive pulmonary disease (COPD) in patients presenting with respiratory symptoms is recommended; however, diagnosing COPD is difficult because a single gold standard is not available. The aim of this article is to review and interpret the existing evidence, theories and consensus on the individual parts of the diagnostic work-up for COPD. Relevant articles are discussed under the subheadings: history taking, physical examination, spirometry and additional lung function assessment. Wheezing, cough, phlegm and breathlessness on exertion are suggestive signs for COPD. The diagnostic value of the physical examination is limited, except for auscultated pulmonary wheezing or reduced breath sounds, increasing the probability of COPD. Spirometric airflow obstruction after bronchodilation, defined as a lowered ratio of the forced volume in one second to the forced vital capacity (FEV1/FVC ratio), is a prerequisite, but can only confirm COPD in combination with suggestive symptoms. Different thresholds are being recommended to define low FEV1/FVC, including a fixed threshold, and one varying with gender and age; however, the way physicians interpret these thresholds in their assessment is not well known. Body plethysmography allows a more complete assessment of pulmonary function, providing results on the total lung capacity and the residual volume and is indicated when conventional spirometry results are inconclusive. Chest radiography has no diagnostic value for COPD but is useful to exclude alternative diagnoses such as heart failure or lung cancer. Extensive history taking is of key importance in diagnosing COPD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22271808

Source DB:  PubMed          Journal:  Neth J Med        ISSN: 0300-2977            Impact factor:   1.422


  4 in total

1.  Analysis of aberrant methylation on promoter sequences of tumor suppressor genes and total DNA in sputum samples: a promising tool for early detection of COPD and lung cancer in smokers.

Authors:  Leda Guzmán; María Soledad Depix; Ana María Salinas; Rosa Roldán; Francisco Aguayo; Alejandra Silva; Raul Vinet
Journal:  Diagn Pathol       Date:  2012-07-20       Impact factor: 2.644

2.  A highly significant association between Cathepsin S gene polymorphisms rs12068264 and chronic obstructive pulmonary disease susceptibility in Han Chinese population.

Authors:  Sheng-Lan Gao; Ya-Hong Wang; Chun-Yan Li; La-Wei Yang; Bao-An Zou; Zu-Guang Chen; Wei-Min Yao; Ze-Qing Song; Jun-Fen Cheng; Zi-Ying Lin; Gang Liu
Journal:  Biosci Rep       Date:  2018-07-18       Impact factor: 3.840

3.  Flow-Volume Parameters in COPD Related to Extended Measurements of Lung Volume, Diffusion, and Resistance.

Authors:  Linnea Jarenbäck; Jaro Ankerst; Leif Bjermer; Ellen Tufvesson
Journal:  Pulm Med       Date:  2013-06-13

4.  Prediction of chronic heart failure and chronic obstructive pulmonary disease in a general population: the Tromsø study.

Authors:  Hasse Melbye; Michael Stylidis; Juan Carlos Aviles Solis; Maria Averina; Henrik Schirmer
Journal:  ESC Heart Fail       Date:  2020-10-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.